Evidence map›Paper›PMID 20382680›Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study.

Joanne B Krasnoff, Shehzad Basaria, Michael J Pencina, Guneet K Jasuja, Ramachandran S Vasan, Jagadish Ulloor, Anqi Zhang, Andrea Coviello, Margaret Kelly-Hayes, Ralph B D'Agostino and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Adverse events associated with testosterone administration.The New England journal of medicine · 2010
    Trial
  8. Trial
  9. Article
  10. Article
  11. Androgens as the "old age stick" in skeletal muscle.Cell communication and signaling : CCS · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Joanne B KrasnoffBoston University School of Medicine, Section of Endocrinology, Diabetes, and Nutrition, 670 Albany Street, Second Floor, Boston, Massachusetts 02118-2393, USA.
Shehzad Basaria
Michael J Pencina
Guneet K Jasuja
Ramachandran S Vasan
Jagadish Ulloor
Anqi Zhang
Andrea Coviello
Margaret Kelly-Hayes
Ralph B D'Agostino
Philip A Wolf
Shalender Bhasin
Joanne M Murabito
Boston University · USFramingham Heart Study · USNational Heart Lung and Blood Institute · US

Funding

TUFTS--FIELDINGP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHALENDER BHASIN · 2008 to 2026
$23.9M
MRI, Genetics &Cognitive Precursors of AD &DementiaR01AG016495 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 1999 to 2016
$12.5M
Population-Based Reference Ranges for TestosteroneR01AG031206 · NIA · BOSTON MEDICAL CENTER · PI BHASIN, SHALENDER, RAMACHANDRAN, VASAN S · 2008 to 2010
$1.4M
Exceptional Aging Across the Life Span: Framingham StudyR01AG029451 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MURABITO, JOANNE M · 2008 to 2011
$1.3M
Novel multi-omics approach to the biology of healthy aging: Framingham StudyR56AG029451 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LUNETTA, KATHRYN L, MURABITO, JOANNE M · 2015 to 2015
$474k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01-HC-25195NIA NIH HHS 1R01AG31206NIA NIH HHS 2R01 AG16495NIA NIH HHS 5P30 AG31679NIA NIH HHS AG029451-01A2NIA NIH HHS P30 AG031679NIA NIH HHS R01 AG016495NIA NIH HHS R01 AG029451NIA NIH HHS R01 AG031206NIA NIH HHS R56 AG029451
6 · The paper itself

Abstract

contextMobility limitation is associated with increased morbidity and mortality. The relationship between circulating testosterone and mobility limitation and physical performance is incompletely understood.

objectiveOur objective was to examine cross-sectional and prospective relations between baseline sex hormones and mobility limitations and physical performance in community-dwelling older men. DESIGN, SETTING, AND

participantsWe conducted cross-sectional and longitudinal analyses of 1445 men (mean age 61.0 +/- 9.5 yr) who attended Framingham Offspring Study examinations 7 and 8 (mean 6.6 yr apart). Total testosterone (TT) was measured by liquid chromatography tandem mass spectrometry at examination 7. Cross-sectional and longitudinal analyses of mobility limitation and physical performance were performed with continuous (per SD) and dichotomized [low TT and free testosterone (FT) and high SHBG vs. normal] hormone levels.

main outcome measuresSelf-reported mobility limitation, subjective health, usual walking speed, and grip strength were assessed at examinations 7 and 8. Short physical performance battery was performed at examination 7.

resultsHigher continuous FT was positively associated with short physical performance battery score (beta = 0.13; P = 0.008), usual walking speed (beta = 0.02; P = 0.048), and lower risk of poor subjective health [odds ratio (OR) = 0.72; P = 0.01]. In prospective analysis, 1 SD increase in baseline FT was associated with lower risk of developing mobility limitation (OR = 0.78; 95% confidence interval = 0.62-0.97) and progression of mobility limitation (OR = 0.75; 95% confidence interval = 0.60-0.93). Men with low baseline FT had 57% higher odds of reporting incident mobility limitation (P = 0.03) and 68% higher odds of worsening of mobility limitation (P = 0.007).

conclusionsLower levels of baseline FT are associated with a greater risk of incident or worsening mobility limitation in community-dwelling older men. Whether this risk can be reduced with testosterone therapy needs to be determined by randomized trials.

Indexed as

Mobility LimitationAdolescentAdultAgedChromatography, High Pressure LiquidCross-Sectional StudiesHand StrengthHealthHumansLongitudinal StudiesMaleMiddle AgedMuscle StrengthOdds RatioPostural BalanceProspective StudiesSex Hormone-Binding GlobulinTestosterone

Identifiers

PMID20382680
PMCPMC2902069
OpenAlexW2155100960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.